- Home
- NBIX vs BSY Comparison
NBIX vs BSY Comparison
Compare NBIX & BSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- BSY
- Stock Information
- Founded
- NBIX 1992
- BSY 1984
- Country
- NBIX United States
- BSY United States
- Employees
- NBIX N/A
- BSY N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- BSY Retail: Computer Software & Peripheral Equipment
- Sector
- NBIX Health Care
- BSY Technology
- Exchange
- NBIX Nasdaq
- BSY Nasdaq
- Market Cap
- NBIX 11.0B
- BSY 12.6B
- IPO Year
- NBIX 1996
- BSY 2020
- Fundamental
- Price
- NBIX $115.71
- BSY $46.59
- Analyst Decision
- NBIX Strong Buy
- BSY Buy
- Analyst Count
- NBIX 20
- BSY 10
- Target Price
- NBIX $163.20
- BSY $52.00
- AVG Volume (30 Days)
- NBIX 1.8M
- BSY 1.4M
- Earning Date
- NBIX 05-05-2025
- BSY 05-07-2025
- Dividend Yield
- NBIX N/A
- BSY 0.60%
- EPS Growth
- NBIX N/A
- BSY N/A
- EPS
- NBIX 2.96
- BSY 0.79
- Revenue
- NBIX $2,412,600,000.00
- BSY $1,385,874,000.00
- Revenue This Year
- NBIX $15.36
- BSY $10.41
- Revenue Next Year
- NBIX $16.34
- BSY $10.37
- P/E Ratio
- NBIX $39.66
- BSY $59.14
- Revenue Growth
- NBIX 21.73
- BSY 10.71
- 52 Week Low
- NBIX $84.23
- BSY $36.51
- 52 Week High
- NBIX $157.98
- BSY $57.19
- Technical
- Relative Strength Index (RSI)
- NBIX 60.88
- BSY 67.81
- Support Level
- NBIX $105.45
- BSY $42.72
- Resistance Level
- NBIX $130.46
- BSY $47.68
- Average True Range (ATR)
- NBIX 4.31
- BSY 1.27
- MACD
- NBIX 1.96
- BSY 0.41
- Stochastic Oscillator
- NBIX 50.22
- BSY 80.71
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About BSY Bentley Systems Incorporated Class B
Bentley Systems is a software vendor that caters to engineers, architects, constructors, and geospatial professionals by enabling design, modeling, simulation, project management, and data management of infrastructure assets. The firm delivers solutions via the cloud, desktop, and hybrid environments. While Bentley is relatively small in comparison with peers like Autodesk, it shines in core specialty areas, like bridge or rail design, as opposed to being more broad-based in its applications. Bentley's largest end market is the public works and utilities sector, which represents approximately two thirds of revenue.